Prelude Capital Management’s Dynavax Technologies DVAX Stock Holding History

Prelude Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-600	Closed	-$5K	–	1943
2020 Q2	$5K	Buy	+600	New	+$3.03K	﹤0.01%	1711
2019 Q1	–	Sell	-400	Closed	-$4K	–	1847
2018 Q4	$4K	Buy	+400	New	+$4.43K	﹤0.01%	1643
2017 Q3	–	Sell	-700	Closed	-$7K	–	1688
2017 Q2	$7K	Buy	+700	New	+$4.55K	﹤0.01%	1435

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Prelude Capital Management's DVAX Position: Q1 2026 in Review

Prelude Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 236,329 shares — an estimated $3.63M sold.

Prelude Capital Management first reported a position in DVAX in Q3 2015 and held it in 9 quarters. The position peaked at $3.63M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Prelude Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Prelude Capital Management sold 236,329 Dynavax Technologies shares in Q1 2026, an estimated $3.63M.
Prelude Capital Management first reported a position in Dynavax Technologies in Q3 2015 and held it in 9 quarters.
Prelude Capital Management's Dynavax Technologies position peaked at $3.63M in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.